Cite
MLA Citation
T Maher et al.. “P168 Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis (IPF): one-year data from post-marketing surveillance in the united states.” Thorax, vol. 71, n.d., p. A175. http://access.bl.uk/ark:/81055/vdc_100144715162.0x000040